11β‐hydroxysteroid dehydrogenase type 1 deficiency in bone marrow‐derived cells reduces atherosclerosis-Reference-Cited by-同舟云学术

11β‐hydroxysteroid dehydrogenase type 1 deficiency in bone marrow‐derived cells reduces atherosclerosis

Published:2013-01-09 Issue:4 Volume:27 Page:1519-1531
ISSN:0892-6638
Container-title:The FASEB Journal
language:en
Short-container-title:FASEB j.

Author:

Kipari Tiina¹,Hadoke Patrick W. F.¹,Iqbal Javaid¹,Man Tak‐Yung¹,Miller Eileen¹,Coutinho Agnes E.¹,Zhang Zhenguang¹,Sullivan Katie M.¹,Mitic Tijana¹,Livingstone Dawn E. W.¹,Schrecker Christopher¹,Samuel Kay²,White Christopher I.¹,Bouhlel M. Amine³,Chinetti‐Gbaguidi Giulia³,Staels Bart³,Andrew Ruth¹,Walker Brian R.¹,Savill John S.⁴,Chapman Karen E.¹,Seckl Jonathan R.¹

Affiliation:

1. British Heart Foundation Centre for Cardiovascular ScienceUniversity of EdinburghEdinburghUK

2. MRC Centre for Regenerative MedicineUniversity of EdinburghEdinburghUK

3. Universite de Lille Nord de FranceInstitut National de la Santé et de la Recherche Médicale (INSERM)Unité Mixte de Recherche (UMR) 1011Universite Droit et Sante de Lille (UDSL)Institut Pasteur de LilleLilleFrance

4. Medical Research Council (MRC) Centre for Inflammation ResearchThe Queen's Medical Research InstituteUniversity of EdinburghEdinburghUK

Funder

Wellcome Trust

Medical Research Council

Society for Endocrinology

British Heart Foundation

Agence Nationale de la Recherche

Publisher

Wiley

Subject

Genetics,Molecular Biology,Biochemistry,Biotechnology

Link